Artemis Investment Management LLP Has $28.08 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Artemis Investment Management LLP reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 42.1% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 53,789 shares of the medical equipment provider’s stock after selling 39,188 shares during the period. Artemis Investment Management LLP’s holdings in Intuitive Surgical were worth $28,076,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the stock. Cadinha & Co. LLC increased its position in shares of Intuitive Surgical by 11.7% during the fourth quarter. Cadinha & Co. LLC now owns 64,943 shares of the medical equipment provider’s stock worth $33,898,000 after acquiring an additional 6,800 shares in the last quarter. Clarius Group LLC lifted its position in Intuitive Surgical by 11.8% in the 4th quarter. Clarius Group LLC now owns 2,089 shares of the medical equipment provider’s stock valued at $1,090,000 after acquiring an additional 220 shares in the last quarter. Oak Ridge Investments LLC boosted its stake in Intuitive Surgical by 69.2% in the 4th quarter. Oak Ridge Investments LLC now owns 17,021 shares of the medical equipment provider’s stock worth $8,884,000 after purchasing an additional 6,961 shares during the period. BNC Wealth Management LLC increased its holdings in Intuitive Surgical by 5.7% during the 4th quarter. BNC Wealth Management LLC now owns 11,148 shares of the medical equipment provider’s stock worth $5,819,000 after purchasing an additional 603 shares in the last quarter. Finally, Moss Adams Wealth Advisors LLC raised its stake in shares of Intuitive Surgical by 14.4% in the 4th quarter. Moss Adams Wealth Advisors LLC now owns 717 shares of the medical equipment provider’s stock valued at $374,000 after purchasing an additional 90 shares during the period. Institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Truist Financial upped their price objective on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $549.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, December 11th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, JPMorgan Chase & Co. raised their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the completion of the transaction, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 over the last ninety days. Insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Up 1.5 %

NASDAQ:ISRG opened at $592.64 on Friday. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $597.68. The firm has a market capitalization of $211.09 billion, a price-to-earnings ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39. The stock’s 50 day moving average price is $540.66 and its two-hundred day moving average price is $498.77.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The business had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Equities research analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.